Popular Stories
- Arcutis Biotherapeutics (N
- Nexgel: Bringing Innovatio
- Ekso Bionics: Advancing Ra
- Esperion: Revolutionizing
- AMSC: Restructuring the Po
- Harrow Inc: Envisioning a
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

Rett Syndrome Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
ANAVEX®2-73: A Potential Blockbuster Drug in the Making!
ANAVEX®2-73: A Potential Blockbuster Drug in the Making!

Anavex Life Sciences Corp (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company that is developing a pipeline of therapeutic candidates that target the Central Nervous System (CNS) by leveraging its expertise in precision genetic medicine. The Company has announced that its predictive biomarker of response established...

30 June, 2021 0 Comments
New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis

Multiple Sclerosis (MS) is one of the diseases that will be covered under the National Neurological Conditions Surveillance System (NNCSS), a system that is being built by the Centers for Disease Control and Prevention (CDC) as part of the 21st Century Cures Act 2016, which has finally received funding in 2019...

13 February, 2019 0 Comments
WordPress Video Lightbox Plugin